Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers
Clinical trial NCT01926626 · COMPLETED
Trial details
- NCT number
- NCT01926626
- Sponsor
- Jed E. Rose
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2014-07-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.